Wednesday, March 21, 2018

EyewireTV -- 30th Anniversary of the First Laser Vision Correction

In this week’s EyewireTV, Regeneron announces results from a phase 3 trial evaluating Eylea (aflibercept) in nonproliferative diabetic retinopathy patients without diabetic macular edema; and Avedro reaches an agreement with the FDA for the design of a phase 3 clinical trial of epithelium-on corneal collagen cross-linking for patients with progressive keratoconus. In the feature, Marguerite McDonald, MD, shares her story of the events leading up to world’s first laser vison correction procedure, which she performed 30 years ago this week.

Watch Video

Wednesday, March 14, 2018

EyewireTV -- SightLife Acquires Kamra Inlay; Family Impact on Cataract Surgery

In this week’s EyewireTV, SightLife Surgical, the world’s largest provider of corneal tissue for transplantation, announces that it will acquire the Kamra inlay from AcuFocus; and Quantel Medical receives FDA approval for its next-generation Compact Touch ophthalmic ultrasound platform. Also, a groundbreaking new study reveals that close family relationships and a strong social network increase the likelihood of older adults getting cataract surgery.

Watch Video

Wednesday, March 07, 2018

EyewireTV -- Big Win for Clearside After Phase 3 Results; New Long-Term CyPass Data

In this week’s EyewireTV, Clearside Biomedical announces positive topline results from its pivotal phase 3 clinical trial of suprachoroidal CLS-TA, which is being evaluated for patients with macular edema associated with noninfectious uveitis; and Alcon presents new long-term data from the COMPASS trial, which is evaluating patients with mild-to-moderate primary open-angle glaucoma undergoing cataract surgery who received the CyPass Micro-Stent. Also, Imprimis Pharmaceuticals launches a new program that allows ophthalmologists and optometrists to order custom compounded formulations on an as-needed basis for their patients.

Watch Video

Wednesday, February 28, 2018

EyewireTV -- Ophthalmologists Speak Out Against New Anthem Anesthesia Guidelines

In this week’s EyewireTV, ophthalmologists oppose controversial new insurance guidelines from Anthem that require cataract surgeons to monitor cataract anesthesia themselves in many cases; and Tomey USA receives FDA 510(k) clearance for its EM-4000 Specular Microscope. Also, a new international study shows that implantations of one, two, or three Glaukos iStents achieved mean unmedicated IOP reductions at 36 months.

Watch Video

Wednesday, February 21, 2018

EyewireTV -- Inflammation Drug Approved; Advice When Prescribing Medications

In this week’s EyewireTV, Icon Bioscience receives FDA approval for Dexycu (dexamethasone intraocular suspension), a dropless therapy for treating inflammation associated with cataract surgery; and researchers at the University of Illinois at Chicago say they have identified a small drug molecule that can clear the herpes simplex-1 virus in the cells of the cornea. Also, in the feature, three leading ophthalmologists provide advice to physicians who want to ensure their patients are getting the appropriately prescribed medication.

Watch Video

Wednesday, February 14, 2018

EyewireTV -- Glaucoma Experts Discuss Future Technologies and Treatment Options

In this week’s EyewireTV, at the annual Glaucoma 360 meeting in San Francisco, experts discuss which technologies and treatments they believe will have a major impact on the way glaucoma patients are treated.

Watch Video
Load More